We are live on ! Find out more
AEGR

Aegerion Pharmaceuticals
AEGR

Delisted

AEGR was delisted on the 29th of November, 2016.

Back to rankings

96 hedge funds and large institutions have $1.03B invested in Aegerion Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 39 increasing their positions, 27 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% more capital invested

Capital invested by funds: $554M → $1.03B (+$476M)

44% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 27

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

1% less funds holding

Funds holding: 97 → 96 (-1)

21% less call options, than puts

Call options by funds: $4.27M | Put options by funds: $5.39M

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
96
Holders Change
-1
Holders Change %
-1.03%
% of All Funds
2.68%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
16
Increased
39
Reduced
27
Closed
16
Calls
$4.27M
Puts
$5.39M
Net Calls
-$1.12M
Net Calls Change
-$8.06M

Top Buyers

Rank Fund Capital Flow
1
ACA
Avoro Capital Advisors
New York
+$14.4M
2
SCM
Sarissa Capital Management
Connecticut
+$9.23M
3
Morgan Stanley
Morgan Stanley
New York
+$6.47M
4
SCM
Scopia Capital Management
New York
+$4.9M
5
BFA
BlackRock Fund Advisors
California
+$4.59M

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$9.48M
2
CS
Credit Suisse
Switzerland
-$4.29M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$3.89M
4
AI
Advent International
Massachusetts
-$3.76M
5
GC
Guggenheim Capital
Illinois
-$3.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
SFM
26
Sphera Funds Management
Israel
$2.04M +$2.67M +150,000 New
Deutsche Bank
27
Deutsche Bank
Germany
$1.66M +$798K +44,823 +58%
CS
28
Candriam SCA
Luxembourg
$1.57M +$32K +1,800 +2%
PP
29
PDT Partners
New York
$1.41M +$434K +24,386 +31%
CC
30
CQS Cayman
Cayman Islands
$1.36M +$1.78M +100,000 New
AL
31
AJO LP
Pennsylvania
$1.25M -$278K -15,600 -15%
BIM
32
BlackRock Investment Management
Delaware
$1.22M -$11.5K -647 -0.7%
TCIM
33
TIAA CREF Investment Management
New York
$1.11M -$359K -20,171 -20%
RHJA
34
Rice Hall James & Associates
California
$1.07M +$99.4K +5,583 +8%
Bank of America
35
Bank of America
North Carolina
$1.06M -$720K -40,423 -34%
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$1.02M -$730K -41,000 -35%
Norges Bank
37
Norges Bank
Norway
$986K +$1.01M +56,561 +355%
Connor, Clark & Lunn Investment Management (CC&L)
38
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$964K +$1.26M +70,900 New
SIM
39
Spark Investment Management
New York
$880K -$1.1M -62,000 -49%
FIM
40
Freedom Investment Management
Connecticut
$866K +$187K +10,514 +47%
AllianceBernstein
41
AllianceBernstein
Tennessee
$806K -$890 -50 -0.1%
HVC
42
Healthcare Value Capital
New Jersey
$680K -$534K -30,000 -38%
Group One Trading
43
Group One Trading
Illinois
$644K +$498K +27,945 +144%
BC
44
Birchview Capital
Vermont
$626K – – –
California State Teachers Retirement System (CalSTRS)
45
California State Teachers Retirement System (CalSTRS)
California
$620K -$3.56K -200 -0.4%
SO
46
STRS Ohio
Ohio
$598K +$783K +44,000 New
Swiss National Bank
47
Swiss National Bank
Switzerland
$597K +$258K +14,500 +49%
TA
48
Teachers Advisors
New York
$531K – – –
Citigroup
49
Citigroup
New York
$488K +$484K +27,204 +312%
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$479K +$38K +2,133 +6%
1
2
3 4 5

AEGR Hedge Fund Activity: Q3 2015 in Review

96 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Aegerion Pharmaceuticals (AEGR) for Q3 2015, worth a combined $1.03B — up 86% from $554M a quarter earlier.

Fund positioning in AEGR was balanced in Q3 2015: 16 funds opened new positions, 16 closed out, 39 added to existing stakes and 27 trimmed.

The largest buyer was Avoro Capital Advisors, opening a new position worth an estimated $14.4M. The largest seller was Broadfin Capital, cutting an estimated $9.48M.

  • 96 institutional investors held Aegerion Pharmaceuticals (AEGR) as of Q3 2015, down from 97 in Q2 2015.
  • Funds reported $1.03B of Aegerion Pharmaceuticals stock for Q3 2015, up 86% quarter-over-quarter.
  • 16 funds opened new Aegerion Pharmaceuticals positions in Q3 2015 and 16 closed out, a net change of 0 holders.
  • The largest Aegerion Pharmaceuticals buyer in Q3 2015 was Avoro Capital Advisors, an estimated $14.4M added.
  • The largest Aegerion Pharmaceuticals seller in Q3 2015 was Broadfin Capital, an estimated $9.48M sold.

Based on aggregated 13F filings for Q3 2015.